PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Clinical trials for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS, CASTRATION-RESISTANT trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive therapy shows promise for tough prostate cancers
Disease control OngoingThis early-stage study tests a radioactive drug called 225Ac-PSMA-617 in men with advanced prostate cancer that has stopped responding to hormone therapy. The goal is to find a safe dose and see if it can shrink tumors, even in men who have already received a similar treatment. A…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE1 • Sponsor: Endocyte • Aim: Disease control
Last updated May 26, 2026 03:58 UTC
-
New drug cocktail targets Hard-to-Treat prostate cancer
Disease control OngoingThis study tests whether combining the drug niraparib with other treatments can help men whose prostate cancer has spread and stopped responding to standard hormone therapy. About 136 participants will receive different drug combinations to find the safest and most effective dose…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Cancer patients monitored for long-term side effects in safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis study enrolls 120 people with different cancers who already received treatment in an earlier study. The goal is to track serious side effects and other health issues over time. No new treatment is given; participants are simply monitored for safety.
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated May 26, 2026 04:15 UTC
-
Prostate cancer drug interaction study: what you need to know
Knowledge-focused OngoingThis study looks at how a drug called JNJ-56021927 affects the way the body processes other common medications in men with castration-resistant prostate cancer. 23 participants will take the study drug along with several other drugs to measure changes in drug levels. The goal is …
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE1 • Sponsor: Aragon Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 04:11 UTC